Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NeOnc Technologies Holdings, Inc. ( (NTHI) ) has shared an announcement.
On April 7, 2025, NeOnc Technologies Holdings, Inc. entered into a lease agreement for new executive offices in Calabasas, California, marking a strategic move to support its operations. The lease spans 63 months, with rent starting at $6,778.25 per month and incremental increases over the term. On April 8, 2025, the company appointed Amir Heshmatpour as President, who will also continue as Executive Chairman. This appointment is expected to enhance the company’s strategic and clinical initiatives, leveraging Heshmatpour’s extensive experience in business development and capital markets.
More about NeOnc Technologies Holdings, Inc.
NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company focused on developing and commercializing central nervous system therapeutics. The company aims to address challenges in overcoming the blood-brain barrier with its NEO™ drug development platform, which includes novel drug candidates like NEO100™ and NEO212™. These therapeutics are in Phase II clinical trials and have FDA Fast-Track and IND status, targeting oncological and neurological conditions.
YTD Price Performance: -25.68%
Average Trading Volume: 62,803
For a thorough assessment of NTHI stock, go to TipRanks’ Stock Analysis page.